2024-01-31 11:09:00
Pharmaceutical company Teva Teva +2.83% Base: 4,236 Opening: 4,270 High: 4,485 Low: 4,267 Value: 39,084,960 Page Quote News Graphs Company profile Recommendations Additional articles on the subject: announced just before the publication of the reports of the intention to split its raw materials activity (API) into in order to flood value. Teva has 4,300 employees in the field and the value of the activity may be worth several billions.
Come and hear about the future of Teva at the Bizportal investment conference (for details and registration). Last year she was on the recommended list of the investment experts at the conference. It has increased by 35% since then.
The split is expected to be completed in the first half of 2025. The split will allow Teva to maximize and diversify its sources of income while focusing the capital invested in the growth of the activity channels. Teva may sell this activity in the future and perform a spin-off for its shareholders (as a dividend distribution in kind) – split its stock and give the shareholders also shares of the new company.
This report should be read with caution. Why does the company report a positive announcement an hour before publishing financial statements. Why didn’t she release the two reports together Does she give us the good news just before the disappointing news? All questions and speculations, we will soon know the answer
The company stated that the move will bring value to investors and will also allow it to invest in new growth strategies in the global API market, which is estimated to be worth $85 billion a year.
“The split will play a significant role in the execution of our growth strategies,” he said CEO Richard Francis. “He will allow us to focus on our core business and also on innovations and new generic drugs that we are working on.”
TAPI, the company that deals in the API field, is a leading supplier of raw materials for pharmaceuticals. TAPI has over a thousand customers all over the world to whom it offers a wide range of 350 substances used in both generic and other drugs.
Comments to the article (0):
Your response has been received and will be published subject to the system policy.
Thanks.
for a new comment
Your response was not sent due to a communication problem, please try again.
Return to comment
#Teva #split #raw #materials #activity #aim #overflowing #stock #jumps